News Medical on MSN
Medicaid Expansion Increases Access to HIV Prevention Medication for High-Risk Populations
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...
Rutgers Health researchers found that prescription rates for preexposure prophylaxis rose overall, but racial disparities ...
Zacks Investment Research on MSN
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal
Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
Opinion
16dOpinion
HIV knows no borders, and the Trump administration’s new strategy leave Americans vulnerable – an HIV-prevention expert explains
The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About 120,000 children under the age of 5 were newly infected with HIV in 2024, ...
Hosted on MSN
HIV Prevention: What You Need to Know
Dr. Jean Van Wyk, Chief Medical Officer at ViiV Healthcare, shares insights on HIV prevention, recent research, and how medicine is helping curb the epidemic. 5 arrested in deaths of Robert De Niro's ...
Sara Paparini has received funding from ViiV Healthcare and Gilead Sciences. Sophie Strachan receives funding from ViiV and Gilead and MSD she is affiliated with Sophia Forum Rosalie Hayes does not ...
HIV, the human immunodeficiency virus that can cause AIDS if left untreated, is much less of a transmission risk today than it was 20 years ago, thanks to public awareness about prevention (and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback